This rapid response by Shirley Nurock was made in response to a BMJ report that the US drug company Biogen is “walking away from its Alzheimer’s drug aducanumab (Aduhelm).”
In answer to the question raised by Mrs Nurock “Is it all just hype, a hoax or hope?” the honest answer is we don’t know.